February 20, 2023

ISN Response to the Earthquakes in Turkey and Syria
The ISN is intensely saddened by the updates on the catastrophic earthquakes in Turkey and Syria. Our thoughts and condolences are with the people affected by this tragedy.
As a professional medical society, the ISN has been in active communication with kidney health professionals on the ground to identify their needs and mobilize necessary connections as they arise.
Sharing, Socialising, and Quizzing - Krissia Wallbach-Massai on YNC Activities at WCN'23, and Why It's an Extra Special Edition
By YNC member Krissia Wallbach-Massai (Brazil)
The ISN Young Nephrologists Committee (YNC) is pleased to announce a fantastic lineup of activities for the young and young at heart at WCN’23 in Bangkok:
The YNC Session
The Young Nephrologist’s quiz-a-thon
Social meeting for younger ISN members
Thank You, ISN Volunteers! Join the World's Largest International Kidney Care Organization - Renew Your ISN Membership Today
Among its thousands of dedicated members, the ISN is privileged to be guided by more than 1300 volunteers, ISN members who generously lend their expertise to ISN committees, granting programs, advocacy initiatives, special events and educational tools.
ISN CME Program Supports Two Speakers to Travel to India to Present on Pediatric Nephrology
In December 2022, the ISN supported members Valerie Luyckx (Switzerland) and Hui Kim Yap (Singapore) to present talks at the 34th National Conference of the Indian Society of Pediatric Nephrology in Mumbai, India.
 ISN News 
More Social and Networking Opportunities Than Ever Before: Register Today to Connect With the Global Kidney Care Community at WCN'23, Bangkok
Deadlines Are Approaching - Submit Your Applications to ISN Granting Programs On Time:
Renal Pathologist ISN Members - One Week Left to Apply for a Bursary to Attend Key Renal Pathology Events in 2023.
Find out more here and apply by February 28, 2023.
Help Your Peers and Expand Your Network: Submit Your Application by March 1 to Become an ISN Mentor
Improve the Detection and Management of NCDs in Your Region: Submit Your Proposal by April 1 for an ISN Clinical Research Grant
Get Training and Support to Provide Better Standards of Patient Care in Your Community: Apply by May 1 for an ISN Fellowship
The ISN “Are Your Kidneys Healthy?” Quiz
Now Available in Bahasa Indonesia - Encourage Your Patients to Take the Quiz!
Approaches to Hypertension and Urinary Tract Infections: Watch and Share Two New Modules in the Open-access Online Kidney Education for Primary Care Physicians Curriculum
Listen to a Discussion on Complement-mediated Kidney Diseases From a Panel of Experts in the Latest Global Kidney Care Podcast
This podcast is supported by Novartis.
Join Young Nephrologists in the ISN Twitter Space as They Discuss the WCN'23 Scientific Program and Activities
 ISN Participates  
ISN President Agnes Fogo Helps Develop Renal Pathology Workshop
Become a Trainer for the Saving Young Lives Initiative: Register for the WCN'23 Workshop Now - Spaces Are Limited!
Catch Up Now! Recording of the ISN Webinar on the “Value of Kidney Biopsies in Tubulointerstitial Kidney Disease: Implications for CKDu” Now Available
“The Silent Killer That Needs Our Voice” - Awareness-Raising Editorial by ISN President Published in the Journal of the American Association of Physicians of Indian Origin
Tuesday, February 21  I  6 p.m. CET
ISN-KDIGO Webinar:
Hepatitis C Guideline Update
Join or renew your membership here to access these webinars
ISN-TTS Webinar:
COVID-19 Lessons Learned and Impact on Solid Organ Transplantation
ISN Webinar:
Pros and Cons of Public-Private Partnership in Developing Dialysis Services in
Resource-limited Settings
ISN i3C (CKDu) Webinar:
Value of Kidney Biopsies in Tubulointerstitial Kidney Disease: Implications for CKDu
ISN South Asia Regional Board Webinar:
Case-based Discussion and Update on the Management of IgA Nephropathy
Access the Latest ISN Journal Articles on Covid-19
Results From Part A of the Multi-center, Double-blind, Randomized, Placebo-controlled Nefigard Trial, Which Evaluated Targeted-release Formulation of Budesonide for the Treatment of Primary Immunoglobulin A Nephropathy
To verify the findings of the 2b NEFIGAN trial, the phase 3 NefigArd trial tested the efficacy and safety of nine months of treatment with Nefecon® versus placebo in adult patients with primary IgAN at risk of progressing to kidney failure.
Nefecon® was well-tolerated and most adverse effects were mild to moderate in severity and reversible, confirming outcomes from the phase 2b NEFIGAN study.
A Pilot Randomized Trial of Intra-dialysis Yoga for Patients with End-stage Kidney Disease
This study evaluated the feasibility of conducting a randomized clinical pilot study to measure the effects of intradialytic yoga on quality of life, self-efficacy, and physical performance among maintenance hemodialysis patients. The feasibility and safety of such a trial were supported by the results.